Platelet Integrins in Tumor Metastasis: Do They Represent a Therapeutic Target?
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Platelet Integrins in Tumor Metastasis: Do They Represent a Therapeutic Target?
Authors
Keywords
-
Journal
Cancers
Volume 9, Issue 12, Pages 133
Publisher
MDPI AG
Online
2017-09-28
DOI
10.3390/cancers9100133
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Platelet GPIIb supports initial pulmonary retention but inhibits subsequent proliferation of melanoma cells during hematogenic metastasis
- (2017) Katrin Echtler et al. PLoS One
- Disulfide Bonds as Regulators of Integrin Function in Thrombosis and Hemostasis
- (2016) Ronit Mor-Cohen ANTIOXIDANTS & REDOX SIGNALING
- Metastasis: new functional implications of platelets and megakaryocytes
- (2016) Raphael Leblanc et al. BLOOD
- Aspirin/antiplatelet agent use improves disease-free survival and reduces the risk of distant metastases in Stage II and III triple-negative breast cancer patients
- (2016) J. Shiao et al. BREAST CANCER RESEARCH AND TREATMENT
- The role of integrins in TGFβ activation in the tumour stroma
- (2016) Zareen Khan et al. CELL AND TISSUE RESEARCH
- Involvement of platelets in tumor cell metastasis
- (2016) Belay Tesfamariam PHARMACOLOGY & THERAPEUTICS
- Research advances on structure and biological functions of integrins
- (2016) Li Pan et al. SpringerPlus
- Purinergic Receptors in Thrombosis and Inflammation
- (2015) Béatrice Hechler et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Regulation of integrins in platelets
- (2015) Joel S. Bennett BIOPOLYMERS
- Platelets in cancer
- (2015) E. Mammadova-Bach et al. Hamostaseologie
- Downregulation of Integrins in Cancer Cells and Anti-Platelet Properties Are Involved in Holothurian Glycosaminoglycan-Mediated Disruption of the Interaction of Cancer Cells and Platelets in Hematogenous Metastasis
- (2015) Wenhui Qian et al. JOURNAL OF VASCULAR RESEARCH
- Fibrillar cellular fibronectin supports efficient platelet aggregation and procoagulant activity
- (2015) Eric Maurer et al. THROMBOSIS AND HAEMOSTASIS
- Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasis
- (2015) Yao-Wen Chang et al. Oncotarget
- Caveolin-1-negative head and neck squamous cell carcinoma primary tumors display increased epithelial to mesenchymal transition and prometastatic properties
- (2015) Alain C. Jung et al. Oncotarget
- RUC-4
- (2014) Jihong Li et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Baicalein inhibits agonist- and tumor cell-induced platelet aggregation while suppressing pulmonary tumor metastasis via cAMP-mediated VASP phosphorylation along with impaired MAPKs and PI3K-Akt activation
- (2014) Sung Dae Kim et al. BIOCHEMICAL PHARMACOLOGY
- The functional role of platelets in the regulation of angiogenesis
- (2014) Tony G. Walsh et al. PLATELETS
- Emerging Evidence for Platelets as Immune and Inflammatory Effector Cells
- (2014) Matthew T. Rondina et al. Frontiers in Immunology
- Platelet-Derived Nucleotides Promote Tumor-Cell Transendothelial Migration and Metastasis via P2Y2 Receptor
- (2013) Dagmar Schumacher et al. CANCER CELL
- Integrin α 6 β 1 Is the Main Receptor for Vascular Laminins and Plays a Role in Platelet Adhesion, Activation, and Arterial Thrombosis
- (2013) Mathieu Schaff et al. CIRCULATION
- MMP-2 Detective Silicon Nanowire Biosensor Using Enzymatic Cleavage Reaction
- (2013) Jin-Ha Choi et al. Journal of Biomedical Nanotechnology
- New Fundamentals in Hemostasis
- (2013) Henri H. Versteeg et al. PHYSIOLOGICAL REVIEWS
- Integrin α5β1, the Fibronectin Receptor, as a Pertinent Therapeutic Target in Solid Tumors
- (2013) Florence Schaffner et al. Cancers
- A humanized single-chain antibody against beta 3 integrin inhibits pulmonary metastasis by preferentially fragmenting activated platelets in the tumor microenvironment
- (2012) W. Zhang et al. BLOOD
- Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials
- (2012) Peter M Rothwell et al. LANCET
- Activated Platelets Interact with Lung Cancer Cells Through P-Selectin Glycoprotein Ligand-1
- (2012) Liang Gong et al. PATHOLOGY & ONCOLOGY RESEARCH
- GPIIb/IIIa inhibitors: From bench to bedside and back to bench again
- (2012) Paul C. Armstrong et al. THROMBOSIS AND HAEMOSTASIS
- Inhibition of MCF-7 breast cancer cell-induced platelet aggregation using a combination of antiplatelet drugs
- (2012) LIAN LIAN et al. Oncology Letters
- The wolf in sheep’s clothing
- (2012) Theresa Placke et al. OncoImmunology
- Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis
- (2011) Myriam Labelle et al. CANCER CELL
- The Androgen Receptor Induces Integrin 6 1 to Promote Prostate Tumor Cell Survival via NF- B and Bcl-xL Independently of PI3K Signaling
- (2011) L. E. Lamb et al. CANCER RESEARCH
- Targeting the Platelet Integrin GPIIb/IIIa
- (2011) Christoph E. Hagemeyer et al. CURRENT PHARMACEUTICAL DESIGN
- A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer
- (2011) Katherine M. Bell-McGuinn et al. GYNECOLOGIC ONCOLOGY
- Distinct Roles for Rap1b Protein in Platelet Secretion and Integrin αIIbβ3Outside-in Signaling
- (2011) Guoying Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Engagement of αIIbβ3 (GPIIb/IIIa) with ανβ3 Integrin Mediates Interaction of Melanoma Cells with Platelets
- (2011) Anke S. Lonsdorf et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The evolution of antiplatelet therapy in cardiovascular disease
- (2011) Omair Yousuf et al. Nature Reviews Cardiology
- Platelets, inflammation and tissue regeneration
- (2011) Alan Nurden THROMBOSIS AND HAEMOSTASIS
- Extracellular Matrix Proteins in Hemostasis and Thrombosis
- (2011) W. Bergmeier et al. Cold Spring Harbor Perspectives in Biology
- Deadly allies: the fatal interplay between platelets and metastasizing cancer cells
- (2010) L. Erpenbeck et al. BLOOD
- Anti-platelet therapy: glycoprotein IIb-IIIa antagonists
- (2010) David J. Schneider BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Integrin Alpha 6 Regulates Glioblastoma Stem Cells
- (2010) Justin D. Lathia et al. Cell Stem Cell
- The laminin binding integrin α6β1 in prostate cancer perineural invasion
- (2010) Isis C. Sroka et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
- (2010) Peter M Rothwell et al. LANCET
- Extracellular Engagement of 6 Integrin Inhibited Urokinase-Type Plasminogen Activator-Mediated Cleavage and Delayed Human Prostate Bone Metastasis
- (2009) M. O. Ports et al. CANCER RESEARCH
- Platelet-Derived Transforming Growth Factor- Down-Regulates NKG2D Thereby Inhibiting Natural Killer Cell Antitumor Reactivity
- (2009) H.-G. Kopp et al. CANCER RESEARCH
- Modified heparins inhibit integrin αIIbβ3mediated adhesion of melanoma cells to plateletsin vitroandin vivo
- (2009) ChunMei Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- Lnk regulates integrin αIIbβ3 outside-in signaling in mouse platelets, leading to stabilization of thrombus development in vivo
- (2009) Hitoshi Takizawa et al. JOURNAL OF CLINICAL INVESTIGATION
- Integrins in platelet activation
- (2009) B. NIESWANDT et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Platelet Adhesion under Flow
- (2009) Zaverio M. Ruggeri MICROCIRCULATION
- Cell Adhesion Mechanisms in Platelets
- (2008) David Varga-Szabo et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Integrin alpha-2 and beta-3 gene polymorphisms and colorectal cancer risk
- (2008) Armin Gerger et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started